Gamida Cell announced that orphan drug designation has been granted by the European Medicines Agency’s Committee for Orphan Medicinal Products regarding NiCord as a treatment for haematopoietic stem cell transplantation, also commonly known as bone marrow transplantation.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
